The main drawback of anti-tumor therapy is its low selectivity. One of the main reasons for this is that cytotoxic agents prevail among anti-tumor drugs. This ground-breaking book reviews one of the most promising approaches to new anti-tumor drugs - superoxide dismutase (SOD) models, and thoroughly delineates their use in combined tumor therapy.
The main drawback of anti-tumor therapy is its low selectivity. One of the main reasons for this is that cytotoxic agents prevail among anti-tumor dru...
